RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1

Breast cancer remains the most common malignancy in women and constantly threatens the lives of patients worldwide. State-of-the-art renewal has indicated the involvement of RUNX-associated transcription factor 2 (RUNX2) in tumorigenesis and cancer progression, yet the detailed information during br...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Wentao, Xu, Xiaodan, Wan, Lijuan, Lv, Fengxu, Wei, Wei, Xu, Xiaojun, Li, Wei, Huang, Dabing, Zhang, Leisheng, Li, Feifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724742/
https://www.ncbi.nlm.nih.gov/pubmed/36483054
http://dx.doi.org/10.3389/fonc.2022.996080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724742/
https://www.ncbi.nlm.nih.gov/pubmed/36483054
http://dx.doi.org/10.3389/fonc.2022.996080

Ejemplares similares